Nursing care
Congenital Hypothyroidism nursing care: what to assess and what to do first
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Congenital hypothyroidism is caught by the newborn screening heel stick, not by symptoms, because most affected infants look normal at birth. Treatment is levothyroxine started within the first two to three weeks of life, and a missed or delayed diagnosis causes permanent intellectual disability that treatment cannot reverse.
Recognising it at the bedside
Most newborns with congenital hypothyroidism show almost nothing on exam in the first days of life, which is precisely why universal screening exists. When signs are present, look for prolonged jaundice past two weeks, a large or protruding tongue, hoarse cry, poor feeding, hypotonia, umbilical hernia, and constipation. Skin can feel cool and dry, and a posterior fontanelle that is unusually large or slow to close is a subtler clue some nurses pick up on exam.
The finding that should never be missed is an abnormal newborn screen result, and the nursing action is speed, not observation. A low T4 or elevated TSH on the screen is a call-the-family-today situation, not something to route through routine follow-up, because every week of delayed treatment has measurable developmental cost.
Why the classic presentation misleads
The textbook description, thick tongue, hoarse cry, umbilical hernia, describes an infant who has already gone untreated for weeks to months. At the point screening exists to catch the condition, most babies have none of these signs yet, so a nurse waiting for the classic picture before acting has already missed the window that matters.
Jaundice is a particular trap. Physiologic jaundice is common and usually resolves within the first one to two weeks, so a nurse can reasonably reassure a family about jaundice on day five without connecting it to thyroid function. Jaundice that persists past two weeks deserves a second look specifically because it can be the only visible clue in an infant whose screen result has not yet come back or was somehow missed.
Priority nursing actions
Confirm the newborn screen was actually drawn and the result received before discharge, and never assume a normal result without seeing it documented. If a result is abnormal or a repeat screen is requested, that communication to the family needs to happen with urgency, framed clearly as time-sensitive, not as a routine follow-up call.
Once levothyroxine is started, the nursing role is administration accuracy and feeding support. The tablet is crushed and given in a small amount of water, breast milk, or formula, never mixed into a full bottle or soy formula, since soy can interfere with absorption; and it is not given with iron or calcium supplements at the same time for the same reason. Weigh the infant regularly and support feeding, since hypotonia and poor suck can make adequate intake a real challenge in the early weeks.
Labs and diagnostics to expect
The newborn screen measures TSH, T4, or both depending on the state's protocol, since screening panels are not identical everywhere. An elevated TSH with low T4 confirms primary congenital hypothyroidism; some states use a T4-first approach with reflex TSH testing, which is worth knowing varies by jurisdiction rather than assuming a single national standard.
A confirmatory venous blood draw follows an abnormal screen, since screening tests are designed to be sensitive rather than perfectly specific and false positives happen. Thyroid ultrasound or a radionuclide scan may be done to identify the cause, commonly thyroid agenesis, an ectopic gland, or dyshormonogenesis, though treatment starts before this workup is complete because the priority is beginning levothyroxine without delay, not waiting on imaging.
Complications and their early signs
The complication that defines this condition is irreversible intellectual disability from untreated hypothyroidism during the period of rapid brain development in infancy. This is why the standard is treatment initiated within the first two to three weeks of life; delay measured in months, not just years, has been associated with lower IQ outcomes in affected children.
Watch for signs that dosing is inadequate despite treatment having started: persistent lethargy, poor weight gain, continued constipation, or a TSH that is not normalising on follow-up labs. Overtreatment has its own signs to watch for, irritability, poor sleep, tachycardia, and excessive weight loss, since the dose is titrated as the infant grows and either direction of error has consequences.
Teaching that changes outcomes
Parents need to understand that this medication is lifelong, not a short course to be stopped once labs normalise. Stopping levothyroxine because the baby 'looks fine' is a real risk of family teaching gaps, since the infant looking well is often the direct result of the medication working, not evidence it is no longer needed.
Teach the administration details specifically: crush the tablet, give with a small amount of liquid rather than a full feed, and keep it separate in timing from soy formula, iron, and calcium supplements. Emphasise the follow-up lab schedule, since dosing needs frequent adjustment as the infant gains weight, and make clear that a missed dose or a sick day is not a reason to stop the medication without checking with the provider first.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pediatrics practice questions are the closest set to what this page covers.
Common questions
When is the newborn screening test done for congenital hypothyroidism?
It is part of the standard heel-stick newborn screen, typically drawn between 24 and 72 hours after birth in most states. Exact timing protocols vary by state newborn screening program, so the local protocol should be confirmed rather than assumed uniform nationwide.
Is congenital hypothyroidism the same as Hashimoto's thyroiditis?
No. Congenital hypothyroidism is present from birth, usually from a structural thyroid gland problem such as agenesis or an ectopic gland, while Hashimoto's is an acquired autoimmune condition that typically develops later in childhood or adulthood. They are managed with the same medication class but have different causes and onset.
What NCLEX-style detail is most commonly tested for this condition?
Expect questions built around the newborn screen catching an infant who looks clinically normal, and around correct levothyroxine administration, particularly that it should not be given with soy formula or iron and calcium supplements. Questions often test whether you recognise persistent jaundice past two weeks as a clue rather than reassuring the family.
Can congenital hypothyroidism be outgrown or does treatment stop eventually?
For most infants with permanent congenital hypothyroidism, treatment is lifelong and is not stopped once the baby appears well. In a smaller subset of cases the condition is transient, and some providers will trial stopping the medication after age two or three under close monitoring, but that decision is made by the provider based on repeat testing, not by families on their own judgement.